Solubiomix Company Profile
✉ Email this page to a colleague
What is the competitive landscape for SOLUBIOMIX
SOLUBIOMIX has three approved drugs.
Drugs and US Patents for Solubiomix
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Solubiomix | AMCINONIDE | amcinonide | LOTION;TOPICAL | 076329-001 | Nov 6, 2002 | RX | No | Yes | ⤷ Start Trial | ⤷ Start Trial | |||||
| Solubiomix | QUIOFIC | folic acid | SOLUTION;ORAL | 216395-001 | Jan 26, 2026 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | |||||
| Solubiomix | COXANTO | oxaprozin | CAPSULE;ORAL | 217927-001 | Oct 20, 2023 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.

